摘要 |
The present invention relates to metabolites of tricyclic amides, and structurally related compounds, represented by the structural formula (I): and pharmaceutically acceptable isomers, salts, solvates or esters of the compound of formula (I), wherein: R<SUB>1 </SUB>is selected from the group consisting of H and -O; R<SUB>2</SUB>-R<SUB>5 </SUB>can be the same or different, each being independently selected from the group consisting of H, -OH, halide, -NH<SUB>2 </SUB>and -O; and, the combination solid-dashed lines independently represent either single bonds or double bonds, wherein the number of combination solid-dashed lines that are double bonds is not greater than 2, and when, the double bonds are not adjacent, and when 0, one of R<SUB>1</SUB>-R<SUB>5 </SUB>is not H. Also disclosed are methods of treatment of proliferative diseases and methods for inhibiting the abnormal growth of cells, and for inhibiting farnesyl protein transferase using the novel compounds. |
申请人 |
SCHERING CORPORATION |
发明人 |
CHOWDHURY, SWAPAN, K.;IANNUCCI, ROBERT, M.;TZE-MING CHAN;ALTON, KEVIN, B.;MINOR, KEITH, P.;ANIMA GHOSAL;WENQING FENG;SHMUEL ZBAIDA;DOLL, RONALD, J. |